Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.

Recent medical research reveals striking differences between surgical and pharmaceutical approaches ... show improved ...

Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.

LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...